Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers

NCT04535414 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

NIH

Sponsor class

Conditions

Gastric Cancer
Gastric Neoplasms
Gastric Adenocarcinoma

Interventions

DEVICE: Cellvizio (Registered trademark) Real-Time In Vivo Cellular Imaging Platform with Confocal Miniprobes
DEVICE: Olympus Graphics Interchange Format (GIF) 190 endoscope
PROCEDURE: Gastric mucosal biopsy

Sponsor

National Cancer Institute (NCI)